Clinical Trials for NETRIS Pharma

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: NETRIS Pharma

Clinical Trials (5)

NCT06203821
Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer
PHASE1Not yet recruiting
25 participants
Started: Sep 1, 2025 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT05546853
Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma
PHASE1Active, not recruiting
43 participants
Started: Mar 28, 2023 · Completed: Jun 16, 2025
1 condition2 sponsors9 locations
NCT05546879
Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable HCC
PHASE1Recruiting
52 participants
Started: Mar 15, 2023 · Completed: Mar 15, 2027
1 condition2 sponsors1 location
NCT05605496
NP137 Clinical and Biological Activities Assessment in Patients With Advanced/Metastatic Solid Tumors Treated by Standard Anti PD-1/PD-L1 Immunotherapies
PHASE2Recruiting
87 participants
Started: Jan 6, 2023 · Completed: Nov 24, 2026
2 conditions2 sponsors5 locations
NCT04652076
GYNecological Cancers Treated with NETrin MAbs in Combination with Chemotherapy and /or Pembrolizumab
PHASE1/PHASE2Active, not recruiting
240 participants
Started: Dec 14, 2020 · Completed: Jul 30, 2026
2 conditions3 sponsors15 locations